Solvent- and concentration-dependent molecular interactions of taxol (Paclitaxel).

Taxol (paclitaxel) is a promising anticancer agent that has been approved for the treatment of ovarian cancer and is under investigation for the therapy of other tumors. Paclitaxel is poorly soluble in water, and information on its physical behavior in hydrophilic and hydrophobic environments is limited. Circular dichroism (CD) and nuclear magnetic resonance spectroscopy were used to investigate the effect of solvent and drug concentration on the solution conformation of paclitaxel. CD is sensitive to paclitaxel's environment, owing to the presence of effective chromophores in the vicinity of several chiral centers. It was found that (i) the conformation of the paclitaxel side chain depends on the polarity of the solvent and (ii) paclitaxel has a tendency to undergo concentration-dependent aggregation in solvents such as chloroform. To account for the observations, a model is proposed in which paclitaxel molecules are held together in stacks by intermolecular hydrogen bonds involving all four exchangeable protons. Intermolecular interactions and self-association of paclitaxel may have impact not only on the physical stability of the drug in existing formulations or investigational vehicles but also on the effect of paclitaxel in the stabilization of cellular microtubules.

[1]  R. Straubinger,et al.  Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. , 1993, Cancer research.

[2]  M. Anteunis Solution conformation of the ionophore A23187 and its magnesium salt , 1977 .

[3]  A. Sharma,et al.  Reversed-phase high-performance liquid chromatographic determination of taxol in mouse plasma. , 1994, Journal of chromatography. B, Biomedical applications.

[4]  A. McPhail,et al.  Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. , 1971, Journal of the American Chemical Society.

[5]  N. F. Magri,et al.  New taxanes from Taxus brevifolia, 2. , 1982, Journal of natural products.

[6]  D. Guénard,et al.  Relationships between the structure of taxol analogues and their antimitotic activity. , 1991, Journal of medicinal chemistry.

[7]  H. Williams,et al.  NMR and molecular modeling study of the conformations of taxol and of its side chain methylester in aqueous and non-aqueous solution. , 1993 .

[8]  R. Donehower,et al.  Taxol: a novel investigational antimicrotubule agent. , 1990, Journal of the National Cancer Institute.

[9]  G. Georg,et al.  Hydrophobic collapse of taxol and taxotere solution conformations in mixtures of water and organic solvent , 1993 .

[10]  H. Fessi,et al.  Effects of free and liposome-encapsulated taxol on two brain tumors xenografted into nude mice. , 1992, In vivo.

[11]  S. Yalkowsky,et al.  A new parenteral vehicle for the administration of some poorly water soluble anti-cancer drugs. , 1987, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[12]  Martin Karplus,et al.  Vicinal Proton Coupling in Nuclear Magnetic Resonance , 1963 .

[13]  J. Beutler,et al.  1H- and 13C-nmr assignments for taxol, 7-epi-taxol, and cephalomannine. , 1992, Journal of natural products.

[14]  K. Nicolaou,et al.  Total synthesis of taxol , 1994, Nature.

[15]  P. Schiff,et al.  Taxol assembles tubulin in the absence of exogenous guanosine 5'-triphosphate or microtubule-associated proteins. , 1981, Biochemistry.

[16]  B. Leyland-Jones,et al.  Hypersensitivity reactions from taxol. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. Suffness,et al.  Chapter 32. Taxol: From Discovery to Therapeutic Use , 1993 .

[18]  L. Grochow,et al.  Phase I trial of taxol in patients with advanced cancer. , 1987, Cancer treatment reports.

[19]  R. Straubinger,et al.  Novel Taxol formulations: Taxol-containing liposomes. , 1993, Journal of the National Cancer Institute. Monographs.

[20]  J. W. Wilson,et al.  Taxol: a history of pharmaceutical development and current pharmaceutical concerns. , 1993, Journal of the National Cancer Institute. Monographs.

[21]  M. De Brabander,et al.  Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Benesi,et al.  Characterization of taxol in methylene chloride by nmr spectroscopy , 1992 .

[23]  P. Schiff,et al.  Promotion of microtubule assembly in vitro by taxol , 1979, Nature.